Hemostatic markers and atrial fibrillation in ARIC
Early Management of Atrial Fibrillation to Prevent Cardiovascular Complications Supported by an unrestricted educational grant from Sanofi.
for internal use only Evidence Based Medicine The Need to Avoid Unnecessary Ventricular Stimulation.
Modeling the Atrial Fibrillation Side Effects of Interleukin-11
